Iotrolan is an organic molecular entity. Nonionic, isotonic contrast medium designed for intrathecal use. IOTROLAN is a Unknown drug with a maximum clinical trial phase of IV that was first approved in 1989. It is grouped under the following drug class(es): CT contrast agents. Its therapeutic use is listed as diagnostic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Osmovist, ZK 39 482 and DTXSID0023165. Its PubChem CID is 3738.
Iotrolan
| CAS No | 79770-24-4 |
|---|---|
| Molecular Formula | C37H48I6N6O18 |
| Molecular Weight | 1626.2 g/mol |
| Synonyms | 2,4,6-triiodo-5-[methyl-[3-oxo-3-[2,4,6-triiodo-N-methyl-3,5-bis(1,3,4-trihydroxybutan-2-ylcarbamoyl)anilino]propanoyl]amino]-1-N,3-N-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Iotrolan is an organic molecular entity. Nonionic, isotonic contrast medium designed for intrathecal use. IOTROLAN is a Unknown drug with a maximum clinical trial phase of IV that was first approved in 1989.
The listed CAS number is 79770-24-4.
The listed molecular formula is C37H48I6N6O18.
The listed molecular weight is 1626.2 g/mol.
2,4,6-triiodo-5-[methyl-[3-oxo-3-[2,4,6-triiodo-N-methyl-3,5-bis(1,3,4-trihydroxybutan-2-ylcarbamoyl)anilino]propanoyl]amino]-1-N,3-N-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide.
The source lists Osmovist, ZK 39 482 and DTXSID0023165.